Closing Bell: Knight Therapeutics Inc up on Thursday (GUD)
In trading today, shares of Knight Therapeutics Inc opened at $5.67 and closed at $5.76. It traded at a low of $5.62 to a high of $5.78.
Share prices advanced 2.13 percent from the previous day's close of $5.64.
During the day across North America, the TSX Composite closed 0.87% at 22544.13, the S&P 500 closed 1.02% at 5633.91, the Dow Jones Industrial Average closed 1.09% at 39721.36 and the Nasdaq Composite closed 1.18% at 18647.45.
Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.
Trading volume was 78,486 on 403 total trades. On average, Knight Therapeutics Inc has traded 60,685 shares over 5 days and 67,428 year-to-date.
The TSX overall saw 4,281 price advancers against 982 declines and 87 unchanged.
During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, in the last 52 weeks, Knight Therapeutics Inc's shares have boosted 18.03 percent, while they have boosted 10.98% since the start of 2024.
Following today's trading, Knight Therapeutics Inc has a market capitalization of $571.76 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.
Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.
Currently, Knight Therapeutics Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
